|
|
| March 18, 2017: Dr. Stephen Ellis and Dr. C. Michael Gibson Discuss: ABSORB III: Everolimus-Eluting Bioresorbable Vascular Scaffolds in |
Dr. Stephen Ellis and Dr. C. Michael Gibson Discuss: ABSORB III: Everolimus-Eluting
Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Disease: Two-Year
Outcomes From the ABSORB III Trial
TBD
[ Download video ] |
|
No comments have been submitted
|